Price
No data yet.
Social Signal Score
Revenue
$1.02M+419.01%Company Profile
- CEO
- Aaron Green
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- Employees
- 23
- Beta
- 1.25
- Country
- US
- Piotroski score
- 4 / 9 (Middling)
- Altman Z-score
- -71.40
Financials
Revenue
$1.02M+419.0%Net Income
$-2.66M-305.7%EBITDA
$-2.23M-272.3%Free Cash Flow
$-1.42M-499.0%EPS (diluted)
$-0.43-149.8%Shares Outstanding (diluted)
61.49M+4010.0%Operating Expenses
$1.87MCash & Debt
$137.0KReturn of Capital
$0.00Revenue by Segment (annual)
$105.0KQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $1.36M | $-2.80M | $-0.60 |
| 2024 | $643.0K | $-10.13M | $-3.60 |
| 2023 | $1.02M | $-33.78M | $-47.70 |
| 2022 | $1.15M | $-30.45M | $-25.10 |
| 2021 | $1.09M | $-2.94M | $-2.00 |
| 2020 | $824.0K | $-2.82M | $-1.90 |
Valuation
ONMDhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
80+14.29%Social Signal Score
Mentions (12)
- Newsglobenewswire.com·5d ago·Negative
…Reports Third Quarter 2026 Financial Results and Reiterates Fourth Quarter 2026 Outlook MINNEAPOLIS, Nov. 17, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet,” the “Company,” “we,” “us” or “our”), a leading provider of First-Party (Direct-from-Source) regulatory decision-grade, AI-driven Real-World Data (RWD), announced financial results for the third quarter ended September 30, 2026, as reported in its Quarterly Report on Form 10-Q filed with the Securities and Exchang…
View source ↗ - Newsglobenewswire.com·13d ago·Neutral
…ar-to-Date of Contracted Bookings and Publishes “OneMedNet by the Numbers” Growth Recap MINNEAPOLIS, Nov. 09, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet,” the “Company,” “we,” “us” or “our”), a leading provider of First-Party (Direct-from-Source) regulatory decision-grade, AI-driven Real-World Data (RWD), today announced that bookings reached approximately $18.76 million year-to-date as of November 6, 2026, of which $1.388 million has been converted to revenue thro…
View source ↗ - Newsglobenewswire.com·16d ago·Neutral
…dNet Reports Preliminary Revenue for Third Quarter 2026 and Fourth Quarter 2026 Outlook MINNEAPOLIS, Nov. 06, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet,” the “Company,” “we,” “us” or “our”), a leading provider of First-Party (Direct-from-Source) regulatory decision-grade, AI-driven Real-World Data (RWD), today announced preliminary revenue results for the third quarter ended September 30, 2026, and provides revenue guidance for the fourth quarter of 2026. The Comp…
View source ↗ - Newsglobenewswire.com·18d ago·Neutral
…eives Mid Six-Figure Re-Order from Foundation Model Company Developing Radiology Models MINNEAPOLIS, Nov. 04, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet,” the “Company,” “we,” “us” or “our”), a leading provider of First-Party (Direct-from-Source) regulatory decision-grade, AI-driven Real-World Data (RWD), today announced that it has received a mid six-figure re-order from a previously announced foundation model company developing advanced AI models for radiology. T…
View source ↗ - Newsglobenewswire.com·19d ago·Neutral
… Receives High Six-Figure Add-On Order Under Multiyear Agreement Announced September 30 MINNEAPOLIS, Nov. 03, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet,” the “Company,” “we,” “us” or “our”), a leading provider of First-Party (Direct-from-Source) regulatory decision-grade, AI-driven Real-World Data (RWD), today announced that it has received a high six-figure add-on order under the multiyear agreement announced on September 30, 2026. The order exercises the expansi…
View source ↗ - Newsglobenewswire.com·34d ago·Neutral
…armaceutical Intelligence Provider as Channel Partner, Extending Reach in Pharma Market MINNEAPOLIS, Oct. 19, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet,” the “Company,” “we,” “us” or “our”), a leading provider of First-Party (Direct-from-Source) regulatory decision-grade, AI-driven Real-World Data (RWD), today announced its 12th channel partner agreement, under which a leading global provider of pharmaceutical intelligence and data solutions will distribute OneMed…
View source ↗ - Newsglobenewswire.com·38d ago·Neutral
…neMedNet Adds Leading Hospital System Provider Network, Expanding By Up to 12 Hospitals MINNEAPOLIS, Oct. 15, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet,” the “Company,” “we,” “us” or “our”), a leading provider of First-Party (Direct-from-Source) regulatory decision-grade, AI-driven Real-World Data (RWD), today announced the addition of a leading hospital system to its iRWD™ platform and federated provider network and expects to expand the network by up to 12 addit…
View source ↗ - Newsglobenewswire.com·46d ago·Neutral
…xpanding the Company's Real World Data Footprint into Korea and the Asia Pacific Region MINNEAPOLIS, Oct. 07, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet,” the “Company,” “we,” “us” or “our”), a leading provider of First-Party (Direct-from-Source) regulatory decision-grade, AI-driven Real World Data (RWD), today announced its 11th channel partner agreement with Mediplexus, a healthcare data company specializing in RWD and Real World Evidence (RWE) and a subsidiary o…
View source ↗ - Newsglobenewswire.com·58d ago·Neutral
OneMedNet Corporation Announces 1-for-10 Reverse Stock Split MINNEAPOLIS, Sept. 25, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (the “Company,” “we,” or “our”), a leading provider of first-party (direct-from-source) regulatory decision-grade, AI-driven Real-World Data (RWD), today announced that it will implement a 1-for-10 reverse stock split of its issued and outstanding shares of common stock (the “Reverse Stock Split”), effective at 12:01 a.m.
View source ↗ - Newsglobenewswire.com·61d ago·Neutral
OneMedNet Expands Commercial Reach Through Multi-Year Resale Agreement with Atropos Health MINNEAPOLIS, Sept. 22, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet,” the “Company,” “we,” “us,” or “our”), a leading provider of regulatory decision-grade, AI-driven Real-World Data (RWD), today announced a strategic partnership with Atropos Health, the creator of real-world evidence for clinical decision-making under a multi-year agreement.
View source ↗ - Newsglobenewswire.com·65d ago·Neutral
OneMedNet Reports Record Bookings as Faster Fulfillment Begins MINNEAPOLIS, Sept. 18, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet,” the “Company,” “we,” “us” or “our”), a leading provider of first-party (direct-from-source) regulatory decision-grade, AI-driven Real-World Data (RWD), today announced year-to-date bookings of approximately $16.2 million, a 16X increase versus the same period in 2025.
View source ↗ - Newsglobenewswire.com·83d ago·Negative
…rm Enables Rapid Feasibility-to-Delivery for Leading AI-Driven Drug Development Company MINNEAPOLIS, Aug. 31, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet,” the “Company,” “we,” “us” or “our”), a leading provider of first-party (direct-from-source) regulatory decision-grade, AI-driven Real-World Data (RWD), today announced a new agreement to deliver de-identified, full-fidelity clinical Real-World Data to a leading AI-driven drug development company. OneMedNet's iRWD…
View source ↗
Insider trading
Open-market buys and sells by ONMD officers and directors.
- Bought
- $6.3m
- Sold
- $322k
60 trades
7 trades
- Yu Jeffreybought
- Kosasa Thomasbought
- Green Aaronsold
- Green Aaronsold
- Golden Robert Lawrencesold
- Golden Robert Lawrencesold
- Golden Robert Lawrencesold
- Yu Jeffreybought
33 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
No disclosed congressional trades in ONMD.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.
